INFUSYSTEM HOLDINGS, INC Finite-Lived Intangible Asset, Expected Amortization, Year One
INFUSYSTEM HOLDINGS, INC (INFU) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $661.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-08-04
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $661.00K.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $661.00K.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $715.00K.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $715.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $661.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $661.00K 10-Q · filed 2026-05-08 |
| 2025-12-31 | $715.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $715.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $695.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $525.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $810.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $810.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | $810.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $810.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $990.00K 10-K · filed 2024-04-10 |
| 2023-09-30 | $990.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $990.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $990.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $990.00K 10-K · filed 2023-03-16 |
| 2022-09-30 | $990.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $990.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $990.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.49M 10-K · filed 2022-03-15 |
| 2021-09-30 | $2.49M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.49M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $2.22M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.93M 10-K · filed 2021-03-22 |
| 2020-09-30 | $3.93M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $3.93M 10-Q · filed 2020-08-14 |
| 2019-12-31 | $4.29M 10-K · filed 2020-03-30 |
| 2018-12-31 | $4.40M 10-K · filed 2019-03-22 |
| 2017-12-31 | $4.65M 10-K · filed 2018-03-19 |
| 2016-12-31 | $5.65M 10-K · filed 2017-03-22 |
| 2015-12-31 | $5.10M 10-K/A · filed 2016-12-12 |
| 2014-12-31 | $2.91M 10-K · filed 2015-03-09 |
| 2013-12-31 | $2.47M 10-K · filed 2014-03-11 |
| 2012-12-31 | $2.62M 10-K · filed 2013-03-28 |
| 2012-09-30 | $2.73M 10-Q · filed 2012-11-14 |
| 2011-06-30 | $1.35M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |